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when evaluating mismatches. We are also preparing to 
further test the method in the daily clinic in parallel with our 
current image review routines for a comparative study.  
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Purpose/Objective: The increased use of image-guided 
radiotherapy (IGRT) has enabled dose-response modelling 
using motion-inclusive (rather than planned) dose 
distributions. Robust motion-inclusive dose-response 
parameters would require both large cohorts and daily 
imaging (e.g. cone-beam CT, CBCT), which could lead to 
substantial clinical work-load including image registration, 
dose-recalculation and dose accumulation. Systematic 
changes in body dimensions (e.g. due to weight loss) during 
the course of RT could potentially assist to determine the 
need for dose-recalculation. The aim of this study was to 
investigate the need for dose-recalculation in a cohort of 
prostate cancer patients treated with IGRT.  
Materials and Methods: From 41 patients treated with IGRT 
for prostate cancer in 2013, five patients were selected 
based on their large treatment-course variations in source-
skin distance (SSD, measured at the anterior, left and right 
side). To isolate the effect of body dimension changes, dose 
re-calculations without heterogeneity corrections were 
performed on the pre-RT CT and on the CBCTs acquired 
during the first phase of RT. The resulting dose distributions 
were compared using the generalised equivalent uniform 
dose (gEUD) for the rectum (a=11) and bladder (a=8), as well 
as the maximum point doses in these organs and in the body. 
Finally, changes in dose metrics between the pre-RT CT and 
the re-calculated dose distributions on the CBCTs were 
correlated (Pearson’s correlation coefficient, Pr) with 
changes in body dimensions. Changes in SSD were quantified 
as the cross-sectional area (CSA) measuring changes in the 
isocenter body contour area (with a rectangular 
approximation), and as the contour surface change (CVC) 
adding surface changes in contour slices close to the 
maximum dose point. 
Results: Overall, dose differences were within 1% (Table 1) 
but differences exceeding 5% were seen for single scans of 
which the majority resulted from a single patient (Figure 1 
(left)). The correlation between CSA and all five dose metrics 
was typically modest with the strongest correlation found 
with the rectum and bladder gEUDs (Pr= -0.63, -0.51, Figure 1 
(right)). The CVC was slightly weaker correlated with the 
rectum gEUD but overall the correlations with the other dose 
metrics remained modest (Table 1). 
 
 
 
Conclusions: Variations in body dimensions during RT for 
prostate cancer were found to cause differences in dose 
distributions typically within 1% although larger individual 
differences (>5%) were seen. Treatment course SSD variations 
can be used as an indicator of the need for CBCT-based re-
calculations to take variations in body dimension into 
account.  
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Purpose/Objective: The use of 18F-fluorodeoxyglucose 
positron emission tomography (FDG-PET) in the delineation 
process in Radiation Oncology is constantly growing. The 
accuracy in metabolic volume sizing is nowadays very 
important in relation to the high conformity of dose 
distributions achievable with modern equipment. 
In this work we propose a new method of automatic tumor 
segmentation based on a Dirichlet process (DP) mixture 
model applied to the distribution of the voxel activity 
concentration in PET-CT images. 
Materials and Methods: We tested the method on a IEC 
phantom acquired by a Philips Gemini Big Bore TF scanner, 
on a digital phantom simulating spherical/uniform lesions and 
tumours (irregular in shape and activity), and on a 
consecutive series of patients. The IEC body phantom 
consisted of 6 spherical inserts with diameters in the range 
10-37 mm. Each sphere was filled with 18FDG using 9 different 
target-to-background ratios (2.5 to 70). The scan time per 
bed was 5 min. The digital phantom simulates 3 spheres with 
uniform activity (volumes of 5, 13 and 37 ml) and 3 irregular 
structures (volumes of 45, 62 and 133 ml). The clinical cases 
were 10 lung cancer and 10 oesophageal cancer patients (2.5 
MBq/kg). We applied an automatic, statistically-based 
